Advanced Proteome Therapeutics Corporation is a development-stage company. The Company through the operations of its subsidiary, Advanced Proteome Therapeutics Inc. (APTI) is a biotechnology company engaged in to develop and commercialize technology platform that is intended for the chemical modification of protein therapeutics. APTI uses advanced protein modification technologies to produce human protein drugs and other protein products, which are to be tested for enhanced therapeutic, diagnostic and analytical properties. The Company applies its technology to the two areas of therapeutics and diagnostics: Protein Drugs, and Personalized Medicine. The Company?s technologies are applicable to site-specifically linking diverse payloads, such as radionuclide chelators for in vivo imaging, an... (Source: SEC reports)
Competitor - 1/7
Which company is more competitive with Anadarko Petroleum?
HOUSTON, Aug. 15, 2018 /PRNewswire/ --Â Anadarko Petroleum Corporation (NYSE : APC ) today announced its board of directors has named Amanda M. McMillian Executive Vice President and General Counsel, [...]
HOUSTON, Sept. 20, 2017 /PRNewswire/ -- Anadarko Petroleum Corporation (NYSE: APC) today announced its board of directors has authorized a $2.5 billion share-repurchase program. The authorization extends [...]